OpenAI Unveils GPT-Rosalind Model for Advancements in Life Sciences
OpenAI has introduced GPT-Rosalind, a new AI model designed specifically for life sciences, including drug discovery and translational medicine. Named after Rosalind Franklin, the model aims to streamline scientific research by improving the selection of research targets and enhancing experimental hypotheses. GPT-Rosalind has been tested on various scientific topics, such as organic chemistry and genetics, and is intended to reduce the time required for drug development and approval. OpenAI has partnered with biotechnology and pharmaceutical companies to ensure the model's responsible use and to support scientific discovery. 
